首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drugs & aging

缩写:DRUG AGING

ISSN:1170-229X

e-ISSN:1179-1969

IF/分区:3.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1531
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lizmarie G Maldonado,Lois J Matthews,Katharine A Fernandez et al. Lizmarie G Maldonado et al.
Background: Emerging evidence in animal models and humans suggests that statins may provide partial protection against noise-induced and drug-induced hearing loss. However, evidence for protection against age-related hear...
Jennifer Bolt,Wade Thompson,Colleen Inglis Jennifer Bolt
Proton pump inhibitors (PPIs) are amongst the most commonly prescribed medications worldwide. Clinical practice guidelines identify clear indications for short-term and long-term use; however, many older adults are prescribed potentially un...
Eléonore Maury,Lorenz Van der Linden,Kris Bogaerts et al. Eléonore Maury et al.
Background: Heart failure with reduced ejection fraction is increasingly prevalent in older adults, yet data on guideline-directed therapies in the oldest age groups remain limited. ...
Shanthi Beglinger,Lisa Bretagne,François Volery et al. Shanthi Beglinger et al.
Background: Knowledge of multiple medication use and medication adherence is important to assess treatment effectiveness and prevent worsening of disease, re-hospitalization, and increased healthcare costs. Limited data e...
Sónia Romano,António Teixeira Rodrigues,José Pedro Guerreiro et al. Sónia Romano et al.
Background: Proton pump inhibitors (PPIs) are commonly used and often prescribed inappropriately, which increases the risk of adverse events. Deprescribing is a health professional-supervised intervention aimed at reducin...
Diana I Brixner,Chenyue Zhao,Hideki Toyosaki et al. Diana I Brixner et al.
Background: Lecanemab is the first anti-amyloid monoclonal antibody with full approval in the US for the treatment of early Alzheimer's disease (AD). This observational study aimed to provide information about patient dem...
Jessie Nguyen,Nicolò Matteo Luca Battisti,Danielle Ní Chróinín et al. Jessie Nguyen et al.
Early-phase clinical trials (EPCTs) are critical for evaluating the safety, tolerability, efficacy and pharmacokinetics of novel oncology therapies. However, older adults are underrepresented in all phases of oncology clinical trials, inclu...